526139 TRABI

Transgene Biotek Share Price

₹3.56 -0.18 (-4.81%)

23 Mar, 2025 03:23

SIP TrendupStart SIP in TRABI

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

  • Over 1 Month -15.84%
  • Over 3 Month -52.47%
  • Over 6 Month -54.48%
  • Over 1 Year -58.6%
SIP Lightning

Smart Investing Starts Here Start SIP with Transgene Biotek for Steady Growth!

Invest Now

Transgene Biotek Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Transgene Biotek Financials

Transgene Biotek Technicals

EMA & SMA

Current Price
₹3.56
-0.18 (-4.81%)
pointer
  • stock-down_img
  • Bearish Moving Average 16
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹3.97
  • 50 Day
  • ₹4.49
  • 100 Day
  • ₹5.32
  • 200 Day
  • ₹6.21

Resistance and Support

3.64 Pivot Speed
  • R3 3.96
  • R2 3.88
  • R1 3.72
  • S1 3.48
  • S2 3.40
  • S3 3.24

What's your outlook on Transgene Biotek?

You can only vote for once

Transgene Biotek Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-01-24 Quarterly Results
2024-11-12 Quarterly Results & A.G.M.
2024-08-10 Quarterly Results
2024-05-30 Audited Results
2024-02-14 Quarterly Results

Transgene Biotek F&O

Transgene Biotek Shareholding Pattern

23.64%
71.87%
4.49%

About Transgene Biotek

  • NSE Symbol
  • TRABI
  • BSE Symbol
  • 526139
  • Chairman & Managing Director
  • Dr. K Koteswara Rao
  • ISIN
  • INE773D01018

Similar Stocks to Transgene Biotek

Transgene Biotek FAQs

Transgene Biotek share price is ₹3 As on 23 March, 2025 | 03:09

The Market Cap of Transgene Biotek is ₹27 Cr As on 23 March, 2025 | 03:09

The P/E ratio of Transgene Biotek is -115.1 As on 23 March, 2025 | 03:09

The PB ratio of Transgene Biotek is 2.5 As on 23 March, 2025 | 03:09

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23